Dr. Benson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3417 Gaston Ave.
Suite 830
Dallas, TX 75246Phone+1 214-826-6021Fax+1 214-823-9745
Summary
- Dr. Daniel Benson is an urologist in Dallas, TX. He received his medical degree from University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine and has been in practice 6 years. He specializes in minimally invasive surgery, stone disease, and surgical oncology and is experienced in metabolic stone disease.
Education & Training
University of Alabama Medical CenterResidency, Urology, 2012 - 2016- University of Alabama Medical CenterInternship, Surgery, 2011 - 2012
The University of Texas Health Science Center at San AntonioClass of 2011
Certifications & Licensure
NM State Medical License 2022 - 2026
TX State Medical License 2016 - 2025
AL State Medical License 2013 - 2016- American Board of Urology Urology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 48 citationsBiochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancerSandeep B. Shelar, Eun Hee Shim, Garrett J. Brinkley, Anirban Kundu, Francesca Carobbio
Clinical Cancer Research. 2018-12-15 - 158 citationsL-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal CancerEun Hee Shim, Carolina B. Livi, Dinesh Rakheja, Jubilee Tan, Daniel Benson
Cancer Discovery. 2014-11-01 - 16 citationsFeasibility of Intracorporeal Robotic-Assisted Laparoscopic Appendiceal Interposition for Ureteral Stricture Disease: A Case Report.Vidhush K. Yarlagadda, Jeffrey W. Nix, Daniel Benson, J. Patrick Selph
Urology. 2017-08-23
Journal Articles
- Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal CancerGarrett Brinkley, Tyler Poston, Vishwas Parekh, Daniel Benson, Dinesh Rakheja, Clinical Cancer Research
Professional Memberships
- Fellow
- Member
- Member
- Dallas County Medical SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
